Evidence map›Paper›PMID 32175335›Full record

ArticleFrontiers in veterinary science2020

Evaluation of Duration of Immunogenicity and Protective Efficacy of Improved Influenza Viral Vector-Based

Aigerim Mailybayeva, Sholpan Ryskeldinova, Nadezhda Zinina, En-Min Zhou, Gourapura J Renukaradhya, Kaissar Tabynov

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in veterinary science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. The Role of Outer Membrane Protein 16 inVeterinary sciences · 2025
    Review
  4. Article
  5. Peptide-Based Vaccines for Tuberculosis.Frontiers in immunology · 2022
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Aigerim MailybayevaLaboratory of Infectious Disease Prevention, Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan.
Sholpan RyskeldinovaLaboratory of Infectious Disease Prevention, Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan.
Nadezhda ZininaLaboratory of Microbiology, Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan.
En-Min ZhouDepartment of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University, Yangling, China.
Gourapura J RenukaradhyaFood Animal Health Research Program, Department of Veterinary Preventive Medicine, College of Food Agricultural and Environmental Sciences, The Ohio State University, Wooster, OH, United States.
Kaissar TabynovBiological Safety Department, Kazakh National Agrarian University, Almaty, Kazakhstan.
Kazakh National Agrarian Research University · KZNorthwest A&F University · CNThe Ohio State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we first evaluated the duration of a protective immune response against

Indexed as

Brucella melitensisinfluenza viral vectorprolonged efficacysmall ruminantsT-cell–mediated immune responsevaccine

Identifiers

PMID32175335
PMCPMC7056664
OpenAlexW3007934277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.